Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
272.60 HKD | -1.45% | +4.44% | +2.25% |
01-21 | Global markets live: Charles Schwab, Apple, Tesla, Enel, GSK... | |
01-21 | BYD Eyes Completion of Indonesian Plant by End-2025 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 123B | 152B | 208B | 415B | 590B | |||||
Other Revenues, Total | 4.42B | 4.66B | 7.86B | 9.28B | 11.85B | |||||
Total Revenues | 128B | 157B | 216B | 424B | 602B | |||||
Cost of Goods Sold, Total | 107B | 127B | 189B | 353B | 483B | |||||
Gross Profit | 20.66B | 29.85B | 27.44B | 71.41B | 120B | |||||
Selling General & Admin Expenses, Total | 8.49B | 9.38B | 11.79B | 25.07B | 38.67B | |||||
Provision for Bad Debts | 477M | 1.15B | 467M | 1.06B | 1.54B | |||||
R&D Expenses | 5.63B | 7.46B | 7.99B | 18.65B | 39.57B | |||||
Other Operating Expenses | 1.32B | 2.14B | 3.03B | 7.22B | 7.28B | |||||
Other Operating Expenses, Total | 15.91B | 20.13B | 23.28B | 52.01B | 87.07B | |||||
Operating Income | 4.75B | 9.72B | 4.16B | 19.4B | 32.44B | |||||
Interest Expense, Total | -3.49B | -3.12B | -1.91B | -1.32B | -1.83B | |||||
Interest And Investment Income | 354M | 215M | 632M | 1.83B | 4.43B | |||||
Net Interest Expenses | -3.13B | -2.91B | -1.28B | 513M | 2.6B | |||||
Currency Exchange Gains (Loss) | 130M | -806M | -533M | 1.22B | 639M | |||||
Other Non Operating Income (Expenses) | -10.85M | -65.2M | 44.34M | -176M | -116M | |||||
EBT, Excl. Unusual Items | 1.74B | 5.94B | 2.4B | 20.96B | 35.57B | |||||
Gain (Loss) On Sale Of Investments | -805M | -324M | -9.78M | -666M | 258M | |||||
Gain (Loss) On Sale Of Assets | -99.75M | -376M | -113M | -876M | -1.05B | |||||
Asset Writedown | - | -193M | -93.29M | -414M | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | 1.6B | 1.83B | 2.34B | 2.08B | 2.5B | |||||
EBT, Incl. Unusual Items | 2.43B | 6.88B | 4.52B | 21.08B | 37.27B | |||||
Income Tax Expense | 312M | 869M | 551M | 3.37B | 5.92B | |||||
Earnings From Continuing Operations | 2.12B | 6.01B | 3.97B | 17.71B | 31.34B | |||||
Net Income to Company | 2.12B | 6.01B | 3.97B | 17.71B | 31.34B | |||||
Minority Interest | -504M | -1.78B | -922M | -1.09B | -1.3B | |||||
Net Income - (IS) | 1.61B | 4.23B | 3.05B | 16.62B | 30.04B | |||||
Preferred Dividend and Other Adjustments | - | - | - | 6.29M | 39.81M | |||||
Net Income to Common Incl Extra Items | 1.61B | 4.23B | 3.05B | 16.62B | 30B | |||||
Net Income to Common Excl. Extra Items | 1.61B | 4.23B | 3.05B | 16.62B | 30B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.5 | 1.47 | 1.06 | 5.71 | 10.32 | |||||
Basic EPS - Continuing Operations | 0.5 | 1.47 | 1.06 | 5.71 | 10.32 | |||||
Basic Weighted Average Shares Outstanding | 3.23B | 2.88B | 2.87B | 2.91B | 2.91B | |||||
Net EPS - Diluted | 0.5 | 1.47 | 1.06 | 5.71 | 10.32 | |||||
Diluted EPS - Continuing Operations | 0.5 | 1.47 | 1.06 | 5.71 | 10.32 | |||||
Diluted Weighted Average Shares Outstanding | 3.23B | 2.88B | 2.87B | 2.91B | 2.91B | |||||
Normalized Basic EPS | 0.18 | 0.67 | 0.2 | 4.13 | 7.2 | |||||
Normalized Diluted EPS | 0.18 | 0.67 | 0.2 | 4.13 | 7.2 | |||||
Dividend Per Share | 0.06 | 0.15 | 0.1 | 1.14 | 3.1 | |||||
Payout Ratio | 262.52 | 85.76 | 79.91 | 9.35 | 13.23 | |||||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | |||||
Supplemental Items | ||||||||||
EBITDA | 14.33B | 22.04B | 17.97B | 39.11B | 74.33B | |||||
EBITA | 6.23B | 12.79B | 7.09B | 24.5B | 36.62B | |||||
EBIT | 4.75B | 9.72B | 4.16B | 19.4B | 32.44B | |||||
EBITDAR | 15.64B | 23.47B | 19.37B | 40.21B | 75.91B | |||||
Total Revenues (As Reported) | 128B | 157B | 216B | - | 602B | |||||
Effective Tax Rate - (Ratio) | 12.84 | 12.62 | 12.19 | 15.97 | 15.9 | |||||
Total Current Taxes | 466M | 769M | 553M | 3.94B | 7.32B | |||||
Total Deferred Taxes | -154M | 99.89M | -1.79M | -569M | -1.4B | |||||
Normalized Net Income | 580M | 1.93B | 575M | 12.01B | 20.93B | |||||
Interest Capitalized | 186M | 52.79M | 7.72M | - | - | |||||
Interest on Long-Term Debt | 769M | 892M | 400M | 369M | 283M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 1.08B | 1.49B | 1.35B | 2.2B | 4.27B | |||||
Selling and Marketing Expenses | 4.26B | 5.06B | 6.08B | 15.06B | 25.21B | |||||
General and Administrative Expenses | 4.14B | 4.32B | 5.71B | 10.01B | 13.46B | |||||
Research And Development Expense From Footnotes | 5.63B | 7.46B | 7.99B | 18.65B | 39.57B | |||||
Net Rental Expense, Total | 1.3B | 1.43B | 1.41B | 1.11B | 1.58B | |||||
Imputed Operating Lease Interest Expense | 573M | 564M | 491M | 407M | 670M | |||||
Imputed Operating Lease Depreciation | 731M | 865M | 914M | 698M | 905M | |||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | 223M | 399M | |||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | 59.27M | 84.17M | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | 184M | 248M | |||||
Stock-Based Comp., Other (Total) | - | 74.3M | 116M | 125M | 142M | |||||
Total Stock-Based Compensation | - | 74.3M | 116M | 591M | 872M |